Cancer management software firm Ziliomics has received funding from the Prospects Oncology Fund to develop its Heliotrope product . "Our investment leverages years of evolving expertise that culminated in this exciting genomics intelligence tool called Heliotrope. While the value of the cash injection has n't been revealed , Ziliomics said the deal would allow it to win more corporate clients and access more financing . It was designed by genomic experts at the Ontario Institute for Cancer Research . It uses artificial intelligence to analyze genomic data and enable doctors to make decisions on patients ' cancer treatments .
Cancer management software firm Ziliomics has received funding from the Prospects Oncology Fund to develop its Heliotrope product . While the value of the cash injection has n't been revealed , Ziliomics said the deal would allow it to win more corporate clients and access more financing . It was designed by genomic experts at the Ontario Institute for Cancer Research . It uses artificial intelligence to analyze genomic data and enable doctors to make decisions on patients ' cancer treatments .